These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32210723)

  • 1. TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.
    Guo S; Liu Y; Gao L; Xiao F; Shen J; Xing S; Yang F; Zhang W; Shi Q; Li Y; Zhao L
    Int J Biol Sci; 2020; 16(8):1335-1348. PubMed ID: 32210723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBC1Domain Family Member 25 deficiency aggravates cerebral ischemia-reperfusion injury via TAK1-JNK/p38 pathway.
    Zhang Z; Ma T; Fu Z; Feng Y; Wang Z; Tian S; Liu Z; Wei W; Li X; Chen J; Zhao W
    J Neurochem; 2022 Feb; 160(3):392-411. PubMed ID: 34837397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
    Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
    Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM100 acts as a TAK1 receptor that prevents pathological cardiac hypertrophy progression.
    Zhang BB; Zhao YL; Lu YY; Shen JH; Li HY; Zhang HX; Yu XY; Zhang WC; Li G; Han ZY; Guo S; Zhang XT
    Cell Commun Signal; 2024 Sep; 22(1):438. PubMed ID: 39261825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway.
    Li J; Yan C; Wang Y; Chen C; Yu H; Liu D; Huang K; Han Y
    Cell Death Dis; 2022 Apr; 13(4):421. PubMed ID: 35490166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.
    Dai C; Luo W; Chen Y; Shen S; Wang Z; Chen R; Wang J; Chattipakorn N; Huang W; Liang G
    Phytomedicine; 2022 Aug; 103():154238. PubMed ID: 35696800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TBC1 domain family member 25 protects against myocardial apoptosis and the proinflammatory response triggered by ischemia-reperfusion injury through suppression of the TAK1-JNK/p38 MAPK signaling cascade.
    Liu Z; Shang F; Li N; Dong W
    In Vitro Cell Dev Biol Anim; 2023 Dec; 59(10):796-810. PubMed ID: 38100060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
    Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
    Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
    Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
    Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats.
    Matsumoto-Ida M; Takimoto Y; Aoyama T; Akao M; Takeda T; Kita T
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H709-15. PubMed ID: 16183734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways.
    Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q
    Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
    Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
    Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.
    Ma ZG; Yuan YP; Zhang X; Xu SC; Kong CY; Song P; Li N; Tang QZ
    Cardiovasc Res; 2019 May; 115(6):1067-1077. PubMed ID: 30407523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1-Dependent Manner.
    Qian Q; Hu F; Yu W; Leng D; Li Y; Shi H; Deng D; Ding K; Liang C; Liu J
    J Am Heart Assoc; 2023 Apr; 12(7):e028628. PubMed ID: 36974751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salidroside ameliorates pathological cardiac hypertrophy via TLR4-TAK1-dependent signaling.
    Guo Z; Liu FY; Yang D; Wang MY; Li CF; Tang N; Ma SQ; An P; Yang Z; Tang QZ
    Phytother Res; 2023 May; 37(5):1839-1849. PubMed ID: 36512326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
    Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
    Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.